Isolated naïve CD4+ T cells preferentially differentiated towards the Th1 lineage in both PD patients (drug-naïve and dopaminergic drug treated) further verified that current symptomatic treatments are unable to modulate ongoing peripheral adaptive immune alterations. The gene discussed is CD4; the disease is Parkinson disease.